Countries Hong Kong
Ascletis Advances ASC36 Oral Amylin Tablet With Strong Preclinical Weight Loss Data
Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady...
February 12, 2026 | News
Everest Medicines Secures Exclusive Asia Pacific Rights To First In Class Dual Target SHPT Therapy MT1013
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturi...
February 06, 2026 | News
Akso Health Group Launches Exploratory Global Patient Support Programme With Nanning Duoling Research Institute To Expand Zero Cost Cancer Care Access
Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") announced the launch of the an exploratory patient support program and a strategic coopera...
February 05, 2026 | News
Insilico Medicine Receives $5 Million Milestone From Menarini Group After First Patient Dosed In Phase 1 Trial Of AI Designed Cancer Therapy
Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone paymen...
February 05, 2026 | News
Ascletis Pharma Reports Positive Phase III Safety Results For Denifanstat In Moderate To Severe Acne
Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...
February 03, 2026 | News
Nuance Pharma’s Ohtuvayre NDA Accepted For Review In China For COPD Maintenance Treatment
Nuance Pharma announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA)...
January 28, 2026 | News
Ascletis Pharma Inc. Advances ASC30 Into U.S. Phase II Diabetes Study With Topline Data Expected In Q3 2026
-Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30&n...
January 27, 2026 | News
AIM Vaccine Advances High Efficiency Diploid Rabies Vaccine Into Final Clinical Stage
AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficie...
January 19, 2026 | News
Zylox Tonbridge Accelerates Global Expansion With Strategic Acquisition Of Optimed
Marks a major milestone in Zylox-Tonbridge's long-term commitment to global expansion Builds an integrated global commercialization platform to accel...
January 19, 2026 | News
GenEditBio Secures US FDA IND Clearance For First In Vivo Genome Editing Trial In TGFBI Corneal Dystrophy
GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. F...
January 06, 2026 | News
Ascletis Secures US FDA IND Clearance For Phase II Diabetes Study Of Oral GLP One Candidate ASC30
-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the effi...
January 06, 2026 | News
Sisram Medical Clears Final Regulatory Step For DAXXIFY Market Entry In China
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio Sisram Medical Ltd (the "Company...
January 06, 2026 | News
Insilico Medicine Signals The Arrival Of AI First Drug Development With HKD 2.27 Billion IPO
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully lis...
December 31, 2025 | News
HKSH Medical Group And Shenzhen Cancer Hospital Formalise Proton Therapy Collaboration Under Healthy China 2030 Framework
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH")...
December 25, 2025 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
